Richtech Robotics Inc. filed a Form 8-K on August 25, 2026, disclosing a board-authorized share repurchase program of up to $12 million and the approval of healthcare cash stipends for its top three executives, with both actions effective August 21, 2026.
Key Highlights
- Share repurchase authorized: The board authorized repurchases of up to $12 million of Class B common stock on or before August 21, 2027.
- Stock class covered: The repurchase program applies to Class B common stock, par value $0.0001 per share.
- Healthcare stipend approved: The compensation committee approved a $750 per bi-weekly paycheck healthcare cash stipend for the CEO, CFO, and COO.
- Annual aggregate cost: The stipend amounts to approximately $19,500 annually in aggregate across the three officers.
- Effective date: Both the repurchase program and the stipend approvals were effective August 21, 2026.
Richtech Robotics Board Approves Buyback and Executive Healthcare Stipends
According to the filing, the board of directors of Richtech Robotics Inc. (NASDAQ:RR) authorized the company to repurchase up to $12 million of its Class B common stock, par value $0.0001 per share, on or before August 21, 2027. The company disclosed that a press release announcing the Stock Repurchase Program was issued on August 21, 2026, and is attached to the filing as Exhibit 99.1.
Separately, the filing disclosed that the compensation committee of the board approved healthcare cash stipends for three named officer roles. Each of the Chief Executive Officer, the Chief Financial Officer, and the Chief Operating Officer is to receive $750 per bi-weekly paycheck, which the filing states amounts to an aggregate of approximately $19,500 annually across all three positions. The approval was also effective August 21, 2026, and was reported under Item 5.02 of the Form 8-K, covering compensatory arrangements of certain officers.
The filing was signed by Zhenwu (Wayne) Huang, identified as Chief Executive Officer and Director, and dated August 25, 2026. Richtech Robotics is incorporated in Nevada, with principal executive offices located at 2975 Lincoln Rd, Las Vegas, NV 89115. The company is identified in the filing as an emerging growth company.
What Was Disclosed
Richtech Robotics disclosed a board-authorized stock repurchase program of up to $12 million expiring August 21, 2027, and a compensation committee approval of $750 bi-weekly healthcare cash stipends for its CEO, CFO, and COO, effective August 21, 2026.




Please wait processing your request...